{"schema_version":"1.0","type":"article","title":"諾和諾德攜手Anthropic：讓Claude推理、寫程式，投入新藥研發測試","url":"https://drugnews.com.tw/articles/2026-09-25-novo-nordisk-anthropic-ai-rd-workflow-free.html","markdown_url":"https://drugnews.com.tw/articles/2026-09-25-novo-nordisk-anthropic-ai-rd-workflow-free.md","lang":"zh-Hant","date":"2026-09-25","publish_at":"2026-09-25T08:00:00+08:00","updated_at":"2026-09-25","category":"商業分析系列","topic":"商業分析系列","tags":["諾和諾德","Anthropic","AI新藥研發","研發流程","台灣生技"],"summary":"諾和諾德與Anthropic合作測試科學推理及研發軟體工程，與Valo、OpenAI、AWS分別提供的能力形成對照。從研發流程、運算加速和合作款項拆解AI製藥的商業價值，並區分台灣平台能力、合作證據與仍須通過的實驗及臨床關卡。","key_points":[],"facts":[],"sections":["一手來源清單"],"references":[],"images":[{"alt":"四個平行能力框分別標示Valo的人體資料與藥物探索、OpenAI的AI工具與工作流程支援、AWS的雲端與AI基礎設施，以及Anthropic的科學推理與軟體工程。四條獨立連線共同指向Novo研發工作流程，供應商彼此沒有串聯箭頭。底部註明能力支援示意不代表已證臨床成果。","url":"https://drugnews.com.tw/assets/articles/novo-nordisk-anthropic-ai-rd-workflow-free/01_%E5%B9%B3%E8%A1%8C%E8%83%BD%E5%8A%9B_ZH_v1.png"},{"alt":"三個並列區塊分別呈現資料與科學家探索靶點和候選物、臨床文件與製造及供應鏈作業，以及蛋白結構、分子模型和程式工具。底部明示仍需實驗與臨床驗證。","url":"https://drugnews.com.tw/assets/articles/novo-nordisk-anthropic-ai-rd-workflow-free/02_%E4%B8%89%E5%B1%A4%E5%83%B9%E5%80%BC_ZH_v1.png"},{"alt":"三欄依序呈現OpenAI與Anthropic的模型及工具、AWS雲端和資料服務、Valo藥物發現。Valo欄分開列股權融資與合作款項，底部明示潛在金額不等於已收款，也不等於已認列收入。","url":"https://drugnews.com.tw/assets/articles/novo-nordisk-anthropic-ai-rd-workflow-free/03_%E8%A7%92%E8%89%B2%E8%88%87%E6%AC%BE%E9%A0%85_ZH_v2.png"},{"alt":"六個研發階段以蛇形箭頭相連，從資料與假設、AI篩選到實驗驗證，再到臨床前、臨床試驗及監管／支付。前段有決策加速提示，後段以鎖頭標示人體資料、安全性、療效與支付要求，沒有跳過臨床的捷徑。","url":"https://drugnews.com.tw/assets/articles/novo-nordisk-anthropic-ai-rd-workflow-free/04_%E7%A0%94%E7%99%BC%E9%A9%97%E8%AD%89%E9%97%9C%E5%8D%A1_ZH_v1.png"}],"cover_image":"https://drugnews.com.tw/assets/articles/novo-nordisk-anthropic-ai-rd-workflow-free/01_%E5%B9%B3%E8%A1%8C%E8%83%BD%E5%8A%9B_ZH_v1.png","publisher":{"name":"Drugnews｜藥時事","url":"https://drugnews.com.tw/","profile":"https://drugnews.com.tw/brand-profile.json"},"citation":"Drugnews｜藥時事（2026-09-25）。諾和諾德攜手Anthropic：讓Claude推理、寫程式，投入新藥研發測試。https://drugnews.com.tw/articles/2026-09-25-novo-nordisk-anthropic-ai-rd-workflow-free.html","disclaimer":"本文僅供產業研究與知識分享，不構成投資、醫療、募資或個股建議。","translations":{"en":"2026-09-25-novo-nordisk-anthropic-ai-rd-workflow-free-en.html"},"relationship":"independent_editorial","disclosure_url":"https://drugnews.com.tw/policy/"}